Plasma metabolites associated with arterial stiffness in patients with type 2 diabetes

[1]  A. Goto,et al.  Japanese Clinical Practice Guideline for Diabetes 2019 , 2020, Journal of diabetes investigation.

[2]  E. Fukusaki,et al.  Identification of Plasma Inositol and Indoxyl Sulfate as Novel Biomarker Candidates for Atherosclerosis in Patients with Type 2 Diabetes. -Findings from Metabolome Analysis Using GC/MS- , 2020, Journal of atherosclerosis and thrombosis.

[3]  T. Berendschot,et al.  The oral glucose tolerance test-derived incremental glucose peak is associated with greater arterial stiffness and maladaptive arterial remodeling: The Maastricht Study , 2019, Cardiovascular Diabetology.

[4]  L. Liang,et al.  Lysine pathway metabolites and the risk of type 2 diabetes and cardiovascular disease in the PREDIMED study: results from two case-cohort studies , 2019, Cardiovascular Diabetology.

[5]  W. Rathmann,et al.  Glucose and insulin levels are associated with arterial stiffness and concentric remodeling of the heart , 2019, Cardiovascular diabetology.

[6]  Xiaoying Gu,et al.  Novel Metabolites Are Associated With Augmentation Index and Pulse Wave Velocity: Findings From the Bogalusa Heart Study , 2019, American journal of hypertension.

[7]  T. Bamba,et al.  Identification of novel serum markers for the progression of coronary atherosclerosis in WHHLMI rabbits, an animal model of familial hypercholesterolemia. , 2019, Atherosclerosis.

[8]  A. Goto,et al.  Japanese Clinical Practice Guideline for Diabetes 2016 , 2018, Journal of diabetes investigation.

[9]  Min Kyung Kim,et al.  Association between triglyceride glucose index and arterial stiffness in Korean adults , 2018, Cardiovascular Diabetology.

[10]  N. Katakami Mechanism of Development of Atherosclerosis and Cardiovascular Disease in Diabetes Mellitus , 2018, Journal of atherosclerosis and thrombosis.

[11]  S. Piro,et al.  HbA1c Identifies Subjects With Prediabetes and Subclinical Left Ventricular Diastolic Dysfunction , 2017, The Journal of clinical endocrinology and metabolism.

[12]  T. Hoffmann,et al.  N-terminal pyroglutamate formation in CX3CL1 is essential for its full biologic activity , 2017, Bioscience reports.

[13]  S. Yamashita,et al.  Homogeneous Assays for LDL-C and HDL-C are Reliable in Both the Postprandial and Fasting State , 2017, Journal of atherosclerosis and thrombosis.

[14]  G. Regolisti,et al.  Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease , 2017, Current Diabetes Reports.

[15]  D. Tarng,et al.  Indoxyl Sulfate: A Novel Cardiovascular Risk Factor in Chronic Kidney Disease , 2017, Journal of the American Heart Association.

[16]  W. Currenti,et al.  Low advanced glycation end product diet improves the lipid and inflammatory profiles of prediabetic subjects. , 2016, Journal of clinical lipidology.

[17]  Z. Massy,et al.  Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target. , 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  Minjoo Kim,et al.  Associations between metabolomic‐identified changes of biomarkers and arterial stiffness in subjects progressing to impaired fasting glucose , 2015, Clinical endocrinology.

[19]  Alex F. Chen,et al.  Dietary Intake of Sugar Substitutes Aggravates Cerebral Ischemic Injury and Impairs Endothelial Progenitor Cells in Mice , 2015, Stroke.

[20]  G. Regolisti,et al.  Alterations of intestinal barrier and microbiota in chronic kidney disease. , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[21]  Masanori Arita,et al.  MS-DIAL: Data Independent MS/MS Deconvolution for Comprehensive Metabolome Analysis , 2015, Nature Methods.

[22]  Minjoo Kim,et al.  Association between Arterial Stiffness and Serum L-Octanoylcarnitine and Lactosylceramide in Overweight Middle-Aged Subjects: 3-Year Follow-Up Study , 2015, PloS one.

[23]  Ji-Hyun Kim,et al.  Brachial-ankle pulse wave velocity for the prediction of the presence and severity of coronary artery disease , 2014, Clinical and experimental hypertension.

[24]  I. Shimomura,et al.  Clinical utility of brachial-ankle pulse wave velocity in the prediction of cardiovascular events in diabetic patients , 2014, Cardiovascular Diabetology.

[25]  R. Vanholder,et al.  The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review. , 2014, Journal of the American Society of Nephrology : JASN.

[26]  Masanori Arita,et al.  MRMPROBS suite for metabolomics using large-scale MRM assays , 2014, Bioinform..

[27]  Yuko Sakurai,et al.  Gut Dysbiosis and Detection of “Live Gut Bacteria” in Blood of Japanese Patients With Type 2 Diabetes , 2014, Diabetes Care.

[28]  S. Shibata,et al.  Efficacy of combined use of three non-invasive atherosclerosis tests to predict vascular events in the elderly; carotid intima-media thickness, flow-mediated dilation of brachial artery and pulse wave velocity. , 2013, Atherosclerosis.

[29]  C. Lau,et al.  Association of subclinical myocardial injury with arterial stiffness in patients with type 2 diabetes mellitus , 2013, Cardiovascular Diabetology.

[30]  M. Hayashi,et al.  Indoxyl sulfate, a uremic toxin, and carotid intima-media thickness in patients with coronary artery disease. , 2013, International journal of cardiology.

[31]  Hsuan-Liang Liu,et al.  Indoxyl sulfate predicts cardiovascular disease and renal function deterioration in advanced chronic kidney disease. , 2012, Archives of medical research.

[32]  Y. Paik,et al.  The association of specific metabolites of lipid metabolism with markers of oxidative stress, inflammation and arterial stiffness in men with newly diagnosed type 2 diabetes , 2012, Clinical endocrinology.

[33]  H. Ueshima,et al.  Brachial–ankle pulse wave velocity predicts all-cause mortality in the general population: findings from the Takashima study, Japan , 2010, Hypertension Research.

[34]  T. Sugiura,et al.  Association between brachial–ankle pulse wave velocity and 3-year mortality in community-dwelling older adults , 2010, Hypertension Research.

[35]  A. Bast,et al.  Erythritol is a sweet antioxidant. , 2010, Nutrition.

[36]  Yasuhiko Tomino,et al.  Revised equations for estimated GFR from serum creatinine in Japan. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[37]  Stéphane Laurent,et al.  Recent advances in arterial stiffness and wave reflection in human hypertension. , 2007, Hypertension.

[38]  H. Struijker‐Boudier,et al.  Expert consensus document on arterial stiffness: methodological issues and clinical applications. , 2006, European heart journal.

[39]  Y. Ouchi,et al.  Serum lipid survey and its recent trend in the general Japanese population in 2000. , 2005, Journal of atherosclerosis and thrombosis.

[40]  S. Haffner Insulin resistance, inflammation, and the prediabetic state. , 2003, The American journal of cardiology.

[41]  A. Yamashina,et al.  Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. , 2002, Hypertension research : official journal of the Japanese Society of Hypertension.

[42]  S. Morikawa,et al.  Increased arterial wall stiffness limits flow volume in the lower extremities in type 2 diabetic patients. , 2001, Diabetes care.

[43]  P. Ducimetiere,et al.  Aortic Stiffness Is an Independent Predictor of All-Cause and Cardiovascular Mortality in Hypertensive Patients , 2001, Hypertension.

[44]  Lianwei Jiang,et al.  Mannitol at clinical concentrations activates multiple signaling pathways and induces apoptosis in endothelial cells. , 1998, Stroke.

[45]  R T Borchardt,et al.  Inhibitory effect of sugars and polyols on the metal-catalyzed oxidation of human relaxin. , 1996, Journal of pharmaceutical sciences.

[46]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..